U.S. market Closed. Opens in 11 hours 20 minutes

CNMD | CONMED Corporation Stock Fundamentals

(Stock Exchange: NYSE)
Analyzing fundamentals for CNMD we got that it has average fundamentals where Valuation is considered to be slightly undervalued, Profitability is unacceptably poor, Growth is exceptionally good and Health is weak.

Valuation (64%)

Company Industry
P/E Ratio (TTM) 23.38 40.66
PEG Ratio (TTM) 3.16 5.42
P/S Ratio (TTM) 1.81 6.33
P/B Ratio (TTM) 2.61 5.87
P/FCF Ratio (TTM) 14.50 37.81
Price to 5YR AVG Earnings Ratio 128.64 59.41
Price to 5YR AVG FCF Ratio 33.77 36.98

Profitability (30%)

Company Industry
ROA (TTM) 4.31% 4.66%
ROE (TTM) 11.71% 25.49%
Net Profit Margin (TTM) 7.74% 7.22%
ROIC 5YR AVG 2.69% 6.54%

Growth (87%)

4QTR AVG 3YR AVG 5YR AVG
EPS 33.52% 150.27% 80.79%
Revenue 1.17% 6.20% 8.15%
Net Income 33.96% 153.49% 82.32%
Cash Flow 23.89% 22.80% 54.79%

Health (44%)

Company Industry
Current Ratio (TTM) 2.34 2.64
Quick Ratio (TTM) 1.13 1.97
D/E Ratio (TTM) 1.10 0.55
Interest Coverage (TTM) 3.95 2.38
Piotroski F-Score 7 6
Altman Z-Score 2.27 7.18
LTL to 5YR AVG FCF 14.23 3.69
Shares Outstanding Growth 5YR AVG 1.76% 1.65%
An error has occurred. This application may no longer respond until reloaded. Reload 🗙